NEWTOWN, Pa., Jan. 9, 2015 /PRNewswire/ -- Michael Whitman, President and CEO of Micro Interventional Devices Inc. a clinical stage medical device company, will present at the 8th Annual OneMedForum Conference in San Francisco at the Marriott Marquis on January 12th, 2015 at 11:00AM.
OneMedForum showcases promising, innovative growth companies in the healthcare and life sciences. Mr. Whitman will be presenting the company's technology, an initial look at the data from the Secure Transapical Access and Closure Study (STASIS) of its Permaseal™ access and closure technology, its plans for commercialization of Permaseal and the opportunity for investment. The Company has recently completed enrollment in STASIS, a CE Mark study evaluating the safety and performance of Permaseal™, with encouraging interim 30-day outcomes.
"I look forward to presenting our Company and having in-depth discussions with interested investors as we prepare for Permaseal's commercial launch. This is an excellent time to invest in Micro Interventional Devices, as much of the regulatory and technology risk has been mitigated," said Mr. Whitman.
Interested parties should try to attend the presentation or schedule a one-on-one meeting through the OneMed Connect meeting request system or by contacting Katherine Whitman at [email protected].
About Micro Interventional Devices, Inc. (MID):
MID designs, develops and commercializes proprietary technologies targeting unmet needs in cardiovascular and general surgery.
SOURCE Micro Interventional Devices, Inc.